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Summary
The crystal structure of integrin v 3 comprises three regions of contact between v and 3. The main contact on v is located in the -propeller while calf-1 and calf-2 domains contribute minor interfaces. Whether or not contacts between calf-1 and calf-2 domains of glycoprotein (GP) IIb ( IIb) and GPIIIa ( 3) play a role in GPIIb/IIIa complex formation has not been established. In this study we analyzed the effects of two naturally occurring mutations in calf-1 and calf-2 domains on GPIIb/IIIa complex formation, its processing and transport to the cell membrane. The mutations investigated were a deletion-insertion in exon 25 located in calf-2 and an in-frame skipping of exon 20 located in calf-1. Mutated GPIIb cDNAs were co-transfected in baby hamster kidney cells with normal GPIIIa ( 3) cDNA. Analysis by flow cytometry failed to demonstrate detectable amounts of GPIIb or GPIIb/IIIa complex on the surface of cells transfected with each mutation, but immunohistochemical staining revealed their intracellular presence. GPIIb was mainly demonstrable as pro-GPIIb by immunoprecipitation of cell lysates expressing each mutation. Differential immunofluorescence staining of GPIIb and cellular organelles suggested that most altered complexes were located in the endoplasmic reticulum. Homology modeling of normal GPIIb based on the v 3 crystal structure revealed similar contacts between v and 3, and IIb and 3. Introduction of the mutations into the model yielded partial disruption of the normal contacts in the corresponding domains. These data suggest that despite partial disruption of calf-1 or calf-2 domain, GPIIb/IIIa complex is formed but its transport from the endoplasmic reticulum is impaired.
Introduction
Platelet aggregation depends on fibrinogen binding to glycoprotein (GP) IIb/IIIa complex ( IIb 3) that is a calcium dependent heterodimer expressed exclusively in megakaryocytes and platelets. 1 GPIIb and GPIIIa are encoded by separate genes, and following their synthesis they are introduced into the endoplasmic reticulum (ER) where they undergo N-linked glycosylation, form disulfide bonds and assemble in GPIIb/IIIa complexes. The complex is then transported to the Golgi apparatus for final oligosaccharide processing and cleavage of single chain pro-GPIIb into mature GPIIb comprising a heavy and light chain. From the Golgi apparatus the complex is
transported to the open canalicular system and then to the granules or plasma membrane. 2, 3 The assembly of GPIIb and GPIIIa as a complex is a prerequisite for its surface expression. 3 A diminished amount or dysfunction of the GPIIb/IIIa complex causes Glanzmann thrombasthenia (GT). GT is transmitted in an autosomal recessive manner and is caused by mutations in either GPIIb or GPIIIa genes. 4 So far more than 60 mutations causing GT have been described and listed in a database. 5 Expression of some of these mutations in heterologous cell cultures has shed light on the functional importance of particular domains within GPIIb and GPIIIa in the assembly of GPIIb/IIIa complex. Similar information has also been derived from immunochemical analyses of soluble GPIIb/IIIa complex and from the crystal structure of soluble v 3 that is closely related to IIb 3. 6, 7 By immunochemical examinations it was demonstrated that the C-terminal region of GPIIb including parts of calf-1 and calf-2 domains is involved in the contact between GPIIb and GPIIIa. 6 The crystal structure of the extracellular part of integrin v 3 revealed that while the main contact between v and 3 lies in the -propeller of v and A domain of 3, additional contacts between calf-1 and calf-2 domains of v and EGF-3, EGF-4 and TD domains of 3 were also depicted. The latter contacts were small and discontinuous and therefore believed not to occur in the membrane bound receptor 7 . This apparent weakness of the contacts could also be inferred from an electron microscopy study which demonstrated that
For personal use only. on . by guest www.bloodjournal.org From GPIIb/IIIa complexes had a globular head with two flexible tails which were sometimes joined together and sometimes spread apart. 8 However, a recent electron microscopy study which included physicochemical measurements of normal and mutated v 3 and IIb 3 demonstrated that in the low affinity state, in solution and on cell surface, the tails of the and subunits have substantial interactions with one another. 9 This study also showed that activation of v 3 resulted in a dramatic rearrangement to an extended conformation in which no association between the tails of the and subunits was displayed. 9 We have previously described two major mutations in the calf-1 and calf-2 domains of the GPIIb gene in patients with GT. One mutation in calf-2, a 6bp-deletion and 31bp-insertion in exon 25
leads to cryptic splicing of exon 25 and results in substitution of Leu786-Asn795
(LHNNGPGTVN) by 8 alternative amino acids (GLHLSIHQ). 10 A second mutation in calf-1, an A G transition in the acceptor splice site of intron 19/exon 20 junction, results in 4 alternatively spliced mRNAs, all lacking exon 20 with 3 of them remaining in frame. 11 In an attempt to clarify the importance of the contact between calf-1 and calf-2 of GPIIb and EGF-3, EGF-4 and TD of GPIIIa we analyzed the effects of these major mutations in calf-1 and calf-2 on GPIIb/IIIa complex formation, its processing and transport to the cell membrane.
Materials and Methods

Antibodies
A rabbit polyclonal antibody recognizing both reduced GPIIb and non-reduced GPIIIa was previously produced in our laboratory. 12 Murine monoclonal antibodies, AP3 specific for GPIIIa and AP2 specific for GPIIb/IIIa complex, were generously provided by Dr. 
Preparation of GPIIb mutant cDNA constructs
Platelet GPIIb mRNA of an Iranian Jewish patient with GT bearing a deletion-insertion mutation in exon 25 was cloned into normal pGEM7-GPIIb (generously provided by Dr.
Newman, the Blood Center of Southeastern Milwaukee, WI) to create GPIIb-alt.25 as described previously. 10 Platelet GPIIb mRNA was also prepared from an Iraqi-Jewish patient with GT who harbored a previously described splice-site mutation.
11 were amplified by PCR and cloned into a plasmid of the TA cloning system (Invitrogen corp., San Diego, CA) and digested with AccI and NruI restriction enzymes. This yielded a cDNA fragment comprising nucleotides 1368 -2198 which was used to replace the corresponding normal cDNA fragment of pGEM7-GPIIb also digested with AccI and NruI restriction enzymes to create GPIIb-del.20.
Full-length normal and mutated GPIIb cDNAs were excised from pGEM7 using EcoRI restriction enzyme. The cohesive ends were filled in with Klenow (Promega, Madison, MI) to create blunt ends, and were subcloned into the PvuII site of pCEP4 mammalian expression vector carrying the hygromycin resistance gene as a selection marker (Invitrogen, San Diego, CA). The transfected cells were selected with medium containing 0.7mg/ml G418 and 0.5mg/ml hygromycin (Boehringer Mannheim GmbH, Germany). Mock were cells expressing GPIIIa and transfected with 1µg of pCEP4 (Invitrogene) and selected for resistance to both hygromycin and G418. Triton X-100) and eluted at 100 o C with reducing loading buffer (40mM Tris pH 6.8, 1.5% SDS, 8% glycerol, 0.01% bromophenol blue and 5% -mercaptoethanol). Immunoblot analyses were performed by 7.5% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), transfer to a polyvinylidenedifluoride (PVDF) membrane (Millipore, Bedford, MA) and subjection to SZ22 monoclonal antibody against GPIIb followed by goat anti mouse IgG peroxidase conjugate (Sigma). Immunoreactive bands on the membrane were detected using ECL luminescence kit (Amersham, Buckinghamshire, UK) and X-ray film exposure. Prestained high molecular weight proteins (Bio-Rad laboratories, Richmond, CA) were used to estimate the molecular weights of the precipitated proteins. In some experiments, immunoprecipitated proteins were treated with Endoglycosidase H (New England Biolabs Inc, Beverly, MA) as recommended by the manufacturer before the samples were analyzed on SDS-PAGE as described.
Assessment of surface expression of GPIIb/IIIa complex by flow cytometry
For immunoprecipitation of the GPIIb/IIIa complex cells were lysed in the same lysis buffer but containing 5mM CaCl 2 . The complex was precipitated either by 3µg of P2, or 5 µl of rabbit antiserum against GPIIIa followed by adding IgG agarose conjugate anti-mouse or anti-rabbit antibody respectively and elution in sample buffer with or without 5% -mercaptoethanol.
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Immunohistochemistry
Transfected BHK cells were grown on glass slides to subconfluence, washed in Tris-buffered saline (pH 7.6) with 5mM CaCl 2 (TBS-Ca), dried for 24 hours at room temperature and fixed in acetone for 15 min at 4 o C. Cells were then incubated in TBS-Ca containing SZ22, AP2 or 10E5 monoclonal antibodies (10-20µg/ml) using alkaline phosphatase-anti alkaline phosphatase kit (APAAP, Dako, Glostrup, Denmark). Antibody binding to the cells was visualized as red staining using light microscopy and Duet TM system (BioView, Rehovot, Israel)
Immunofluorescence microscopy
Transfected cells were grown on 12mm cover slips, washed in PBS and fixed in acetone:methanol (1:1) as previously described. 13 Cells were incubated for 1 hour at room temperature with 1:1000 dilution of SZ22 monoclonal antibody against GPIIb, and either rabbit anti rat mannosidase II or rabbit anti canine calnexin carboxyl terminus, followed by 1 hour incubation with 1:70 FITC conjugate goat anti mouse IgG or 1:40 TR conjugate goat anti rabbit IgG, respectively. The cover slips were coated with antifade solution (Oncor, Gaitersburg, MD) and analyzed using Duet TM system.
Pulse-chase analysis
Transfected cells were metabolically labeled with [ 35 S]-methionine and chased for 1-24 hours as previously described 13 . Total GPIIb was immunoprecipitated from cell lysates with 3µg SZ22 monoclonal antibody, and the GPIIb fraction complexed with GPIIIa was precipitated with AP3 15 The sequences of IIb (XP_045985), v (XP_002379) and 4 (XP_039011)
were aligned by Pileup algorithm (GCG, Accelrys Inc.). Normal and mutant GPIIb models and the v template were superimposed by structure using the appropriate InsightII option. The amino acids of calf-1 and calf-2 domains of IIb located in the interface with 3 subunit at 5Å distance were marked and the nature of the contact analyzed using CSU software. 16 For
Results
GPIIb is formed but not surface expressed in cells transfected with GPIIb mutants
FACS analyses with monoclonal antibodies SZ22 and 10E5 recognizing GPIIb and GPIIb/IIIa, respectively demonstrated lack of surface expression of GPIIb and GPIIb/IIIa in cells transfected with alt.25 or del.20 mutations (Figure 1 ). Using AP3 monoclonal antibody against GPIIIa detected GPIIIa on the surface of cells containing normal as well as mutant GPIIb. This resulted from complex formation between human GPIIIa and hamster v, as previously described. 13, 17 Immunohistochemistry experiments using SZ22 antibody showed that expression of GPIIb occurred in cells transfected with normal GPIIIa and GPIIb-alt.25 ( Figure 2 ). In cells containing the GPIIb-del.20 mutation only weak staining with SZ22 was observed. These results indicate that the mutated forms of GPIIb were absent from the cell membrane but present intracellularly.
To further analyze the nature of the mutant forms of GPIIb, cell lysates were first immunoprecipitated with polyclonal antibody against GPIIb and GPIIIa and then subjected to SDS-PAGE with -mercaptoethanol followed by western blotting using SZ22 monoclonal antibody. Cells transfected with normal GPIIb displayed two bands corresponding to mature GPIIb and pro-GPIIb ( Figure 3A ). Cells transfected with GPIIb-alt.25 exhibited only one band which migrated as pro-GPIIb and cells transfected with GPIIb-del.20 exhibited a fast migrating pro-GPIIb corresponding to the predicted deletion of 50 amino acids of exon 20 ( Figure 3A ). In these experiments the amount of both mutated GPIIb proteins particularly GPIIb-del.20 was lower than the amount of WT GPIIb. When immunoprecipitation was carried out with a monoclonal antibody CA3 against GPIIb, and immunoblotting was performed with SZ22 monoclonal antibody an additional smaller GPIIb -related band was observed in both GPIIbalt.25 and GPIIb-del.20 ( Figure 3B ). These smaller bands probably represent in vivo-generated degraded GPIIb because cell lysates were prepared in the presence of protease inhibitor cocktail contained in the commercial tablets. To further analyze whether or not the mutants of GPIIb formed GPIIb/IIIa complexes, we examined the co-precipitation of mutants and normal GPIIb with GPIIIa using an antibody against GPIIIa. Cell lysates expressing each mutant of GPIIb (and normal GPIIIa) were first immunoprecipitated with polyclonal antibody against GPIIIa and then immunoblotted with a mixture of monoclonal antibodies SZ22 against GPIIb and AP3 against GPIIIa. Figures 4A and   4B show that both GPIIIa and GPIIb were clearly demonstrable in reduced and non-reduced gels containing WT and the mutants of GPIIb. Notably, in non-reduced conditions, the SZ22 antibody similarly recognized WT GPIIb and the mutants of GPIIb ( Figure 4B ). Immunoprecipitation of cell lysates with monoclonal antibody P2 recognizing GPIIb only when complexed with GPIIIa, also revealed pro-and mature normal GPIIb, pro-GPIIb-alt.25 and a band corresponding to proGPIIb-del.20 ( Figure 4C ). Degraded GPIIb (shown in figure 3B ) was absent in these gels. When GPIIb complexed with GPIIIa was precipitated by AP3 and analyzed with SZ22 in immunoblotting and long exposure, small amounts of mature GPIIb-alt.25 and minute amount of mature GPIIb-del.20 were demonstrable ( Figure 4D ). Taken together, these experiments indicate that GPIIb/IIIa complexes are formed in cells harboring GPIIb-alt.25 and GPIIb-del.20. Figure 5B shows that while WT mature GPIIb was resistant to EndoH digestion (migration was similar), both mutants del.20 and alt.25 GPIIb were EndoH-sensitive similarly to WT pro-GPIIb as depicted by a change in their migration in reduced gel.
GPIIb/IIIa complex is formed in cells expressing the GPIIb mutants
Stability of the GPIIb mutants.
To examine intracellular stability of the GPIIb mutants, cells harboring them were pulselabeled with [
35 S]-methionine for 30 minutes and then lysed or chased with unlabeled methionine for 1-24 hours and than lysed. Total GPIIb was immunoprecipitated from cell lysates using SZ22. Figure 4D ). Taken together, these data suggest that the mutants GPIIb-del.20 and alt.25 were mostly localized in the ER and only trace amounts reached the Golgi apparatus.
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The effects of the GPIIb mutants on the contact between GPIIb and GPIIIa
The models of -propeller, calf-1 and calf-2 domains of GPIIb were structurally superimposed with -propeller, calf-1 and calf-2 domains of v, and the contacts of the respective domains with 3 subunit seemed to be similar ( Figure 8A ). The crystal structure of v 3 was originally resolved at a resolution of 3.1Å, 7 which does not enable accurate determination of interatomic distances. Nevertheless, approximations of important interactions, which stabilize the structure of the complex and the size of the interface between v and 3 were calculated by CSU software. 16 The size of the v -propeller interface with 3 was the largest (2428 Å amino acids of wild type GPIIb. As a result of this shift, His788 was not anymore in a position which allows contact with Tyr594 of 3. Also, the distance between Glu785 and Tyr594 was increased in comparison with the normal interactions ( Figure 8C ). Hence, GPIIb-alt.25 is predicted to disrupt the contact of calf-2 domain with EGF-4 of 3 (147Å 2 ) but does not affect the other contacts with TD.
For
Discussion
The presented data show that two major mutations, GPIIb-del.20 and GPIIb-alt.25 in the calf-1 and calf-2 domains, respectively enable GPIIb/IIIa complex formation but impair its transport from the ER to the Golgi apparatus leading to absent surface expression of this complex. The mutants of GPIIb were detectable mostly as pro-GPIIb (Figures 3-5 ) and were localized mainly in the ER (Figure 7) , findings which are consistent with conversion of pro-GPIIb to mature GPIIb in the Golgi apparatus 2 . Immunoprecipitation and pulse-chase experiments revealed that mutant GPIIb/IIIa complexes did form, although in apparently decreased amount, despite the markedly deranged GPIIb mutant proteins. The stability of the mutant proteins when complexed with normal GPIIIa appeared to be unimpaired ( Figure 6 ). However, because of the limitation of pulsechase experiments it can not be ruled out that some degradation of GPIIb mutants occurred within the 30 minutes of the pulse ( Figure 6 ). The presence of a GPIIb degradation product derived from the mutant proteins but not from normal GPIIb ( Figure 3B) is consistent with such an assumption.
Decreased amounts of mutant GPIIb proteins were also observed in immunostaining experiments Other, albeit point mutations in the calf-2 domain, e.g., Q747P, 18 or in the calf-1 domain, e.g., C674R 19 were also associated with preserved intracellular complex formation yet with profoundly reduced surface expression. Moreover, major mutations in the calf-2 23 were also shown to enable GPIIb/IIIa complex formation, but impaired carbohydrate processing and surface expression of the complex. Finally, even a mutation associated with a deletion of both calf-1 and calf-2 domains (Arg597stop) was recently found to enable formation of an unstable and rapidly degradable GPIIb/IIIa complex. 24 Taken together, these observations suggest that significant changes in calf-1 or calf-2 domains do not prevent GPIIb/IIIa complex formation but do impair its transport to the cell surface, probably by its retention and degradation in the ER. consequently been shown to be associated with rapid degradation of the uncomplexed GPIIb mutants (del A106-Q111, del S129-S161, E324K). 25 In contrast, missense mutations in the calcium binding domain of the -propeller, located away from the interfaced, G242D, R327H, G418D 25 were shown to enable GPIIb/IIIa complex formation but resulted in its retention in the ER. These observations indicate that the calcium-binding domain is also essential for the transport of the GPIIb/IIIa complex from the ER to the Golgi. 25, 26 Our analyses of the GPIIb/IIIa model that was based on the crystal structure of v 3 showed that significant contacts exist between calf-1 of v or IIb and EGF-3 of 3 and between calf-2 of v or IIb and EGF-4 and TD of 3. Similar contacts between GPIIb and GPIIIa have also been
shown by immuno-chemical methods, 6 and by a recent electron microscopy study that involved physicochemical measurements. 9 In our analyses of the model, which is purely theoretical and unsupported by experimental data, the respective contacts were partially disrupted in mutant 27, 28 and in GPIIb-del.20 there was a deletion of 3 amino acids that are in the contact area with 3 ( Figure 8 ). Notwithstanding these significant disruptions, intracellular GPIIb/IIIa complex formation was formed and was stable. This supports the notion that the contacts between GPIIb and GPIIIa in the region of calf-1 and calf-2 domains are not essential for GPIIb/IIIa complex formation, but apparently stabilize its bent conformation 9 . We speculate that the partial disruption of these contacts in del. 20 Shown is western blot analysis using anti GPIIb antibody (SZ22) of SDS-PAGE 
